Unlike earlier secretagogues, Ipamorelin demonstrates strong receptor specificity in research models
Mustafa Ahmed, MD, FACS, FAACS, our practice combines expert knowledge with a personalized approach to weight loss that is as unique as you are
The science behind the medication supports it as an incredibly safe and effective way for patients to achieve positive changes in the way they view and think about food
The starting dose is often part of the adjustment phase, but treatment plans vary by individual
PlexusDx connects eligible patients with qualified providers who conduct thorough medical evaluations, review biomarkers and family history, and may use genetic insights into peptide-response pathways to support individualized treatment decisions
Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes